Chevalier J - Search Results

1

Access to innovation: is there a difference in the use of expensive anticancer drugs between French hospitals?

Bonastre J, Chevalier J, Van der Laan C, Delibes M, De Pouvourville G. Bonastre J, et al. Among authors: chevalier j. Health Policy. 2014 Jun;116(2-3):162-9. doi: 10.1016/j.healthpol.2013.11.006. Epub 2013 Nov 20. Health Policy. 2014. PMID: 24314625

2

Implications of learning effects for hospital costs of new health technologies: the case of intensity modulated radiation therapy.

Bonastre J, Noël E, Chevalier J, Gerard JP, Lefkopoulos D, Bourhis J, Bensadoun RJ, de Pouvourville G; STIC IMRT 2002 Investigators. Bonastre J, et al. Among authors: chevalier j. Int J Technol Assess Health Care. 2007 Spring;23(2):248-54. doi: 10.1017/S026646230707033X. Int J Technol Assess Health Care. 2007. PMID: 17493311

3

The economic burden of melanoma in France: assessing healthcare use in a hospital setting.

Chevalier J, Bonastre J, Avril MF. Chevalier J, et al. Melanoma Res. 2008 Feb;18(1):40-6. doi: 10.1097/CMR.0b013e3282f36203. Melanoma Res. 2008. PMID: 18227707

4

Length and cost of hospital stay of radioiodine ablation in thyroid cancer patients: comparison between preparation with thyroid hormone withdrawal and thyrogen.

Borget I, Remy H, Chevalier J, Ricard M, Allyn M, Schlumberger M, De Pouvourville G. Borget I, et al. Among authors: chevalier j. Eur J Nucl Med Mol Imaging. 2008 Aug;35(8):1457-63. doi: 10.1007/s00259-008-0754-9. Epub 2008 Apr 2. Eur J Nucl Med Mol Imaging. 2008. PMID: 18385999

5

Cost-effectiveness of intraperitoneal chemohyperthermia in the treatment of peritoneal carcinomatosis from colorectal cancer.

Bonastre J, Chevalier J, Elias D, Classe JM, Ferron G, Guilloit JM, Marchal F, Meeus P, De Pouvourville G. Bonastre J, et al. Among authors: chevalier j. Value Health. 2008 May-Jun;11(3):347-53. doi: 10.1111/j.1524-4733.2007.00249.x. Value Health. 2008. PMID: 18489663 Free article.

6

Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin.

Elias D, Lefevre JH, Chevalier J, Brouquet A, Marchal F, Classe JM, Ferron G, Guilloit JM, Meeus P, Goéré D, Bonastre J. Elias D, et al. Among authors: chevalier j. J Clin Oncol. 2009 Feb 10;27(5):681-5. doi: 10.1200/JCO.2008.19.7160. Epub 2008 Dec 22. J Clin Oncol. 2009. PMID: 19103728

7

Valuing EQ-5D using time trade-off in France.

Chevalier J, de Pouvourville G. Chevalier J, et al. Eur J Health Econ. 2013 Feb;14(1):57-66. doi: 10.1007/s10198-011-0351-x. Epub 2011 Sep 21. Eur J Health Econ. 2013. PMID: 21935715

8

Modeling of the impact on health outcomes of the use of dabigatran in patients with atrial fibrillation.

Chevalier J, Giroud M, de Pouvourville G. Chevalier J, et al. Cerebrovasc Dis. 2013;35(4):320-6. doi: 10.1159/000347074. Epub 2013 Apr 23. Cerebrovasc Dis. 2013. PMID: 23615428

9

Cost-effectiveness of dabigatran versus vitamin K antagonists for the prevention of stroke in patients with atrial fibrillation: a French payer perspective.

Chevalier J, Delaitre O, Hammès F, de Pouvourville G. Chevalier J, et al. Arch Cardiovasc Dis. 2014 Jun-Jul;107(6-7):381-90. doi: 10.1016/j.acvd.2014.04.009. Epub 2014 Jun 24. Arch Cardiovasc Dis. 2014. PMID: 24973113 Free article.

10

CAPECO: Cost evaluation of community acquired pneumonia managed in primary care.

Personne V, Chevalier J, Buffel du Vaure C, Partouche H, Gilberg S, de Pouvourville G. Personne V, et al. Among authors: chevalier j. Vaccine. 2016 Apr 27;34(19):2275-80. doi: 10.1016/j.vaccine.2016.03.013. Epub 2016 Mar 12. Vaccine. 2016. PMID: 26979138

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

671 results

Search Page

Filters